Cas 1190213-48-9,N-(4-acetyl-2-bromophenyl)-2-(4-(3,4-dichlorophenyl)-1,2,3-selenadiazol-5-ylthio)acetamide

1190213-48-9

Post Buying Request

Basic information

Product Name: N-(4-acetyl-2-bromophenyl)-2-(4-(3,4-dichlorophenyl)-1,2,3-selenadiazol-5-ylthio)acetamide
Synonyms: N-(4-acetyl-2-bromophenyl)-2-(4-(3,4-dichlorophenyl)-1,2,3-selenadiazol-5-ylthio)acetamide
CAS NO:1190213-48-9
Molecular Formula:
Molecular Weight: 564.148
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-(4-acetyl-2-bromophenyl)-2-(4-(3,4-dichlorophenyl)-1,2,3-selenadiazol-5-ylthio)acetamide(CAS DataBase Reference)
NIST Chemistry Reference: N-(4-acetyl-2-bromophenyl)-2-(4-(3,4-dichlorophenyl)-1,2,3-selenadiazol-5-ylthio)acetamide(1190213-48-9)
EPA Substance Registry System: N-(4-acetyl-2-bromophenyl)-2-(4-(3,4-dichlorophenyl)-1,2,3-selenadiazol-5-ylthio)acetamide(1190213-48-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1190213-48-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1190213-48-9 Suppliers

Recommended suppliers

1190213-48-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1190213-48-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,0,2,1 and 3 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1190213-48:
(9*1)+(8*1)+(7*9)+(6*0)+(5*2)+(4*1)+(3*3)+(2*4)+(1*8)=119
119 % 10 = 9
So 1190213-48-9 is a valid CAS Registry Number.

1190213-48-9Upstream product

1190213-48-9Downstream Products

1190213-48-9Relevant academic research and scientific papers

1,2,3-Selenadiazole thioacetanilides: Synthesis and anti-HIV activity evaluation

Zhan, Peng,Liu, Xinyong,Fang, Zengjun,Pannecouque, Christophe,Clercq, Erik De

, p. 6374 - 6379 (2009)

The development of new HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) offers the possibility of generating novel structures of increased potency. Based on the bioisosteric principle, novel series of 1,2,3-selenadiazole thioacetanilide deri

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1190213-48-9